Andrew Witty takes on a new CEO position
March 15, 2018Medical Communications Andrew Witty, GSK, Optum, UnitedHealth, biotech, drugs, pharma, pharmaceutical
Andrew Witty, who made his name working his way up the ranks at GSK to become its CEO, has revealed …
Top 5 Reasons Why You Should Attend Veeva R&D Summit, Europe
March 15, 2018Medical Communications biotech, drugs, pharma, pharmaceutical, veeva
Veeva R&D Summit, Europe is an annual gathering of pharma, biotech and medical devices professionals in clinical, regulatory, quality, and …
Takeda’s CFO departs forcing company to act
March 14, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, biotech, drugs, pharma, pharmaceutical
Takeda has announced that its Chief Financial Officer, James Kehoe, has decided to move on from the company to take …
Teva denies wrongdoing in Cephalon pay-to-delay deal hearing
March 14, 2018Research and Development, Sales and Marketing Cephalon, Pay to delay, Provogil, Teva, pay-to-delay, pharma
Teva has denied allegations from the European Commission (EC) that it engaged in illegal anti-competitive pay-to-delay tactics to maintain its …
Hammond suggests NHS may receive cash boost
March 14, 2018Medical Communications, Research and Development Autumn Budget, NHS, UK, biotech, drugs, pharma, pharmaceutical
The pressures on the NHS over the winter months exposed serious cracks in the service, with issues regarding underfunding, struggles …
US “right to try” experimental drug bill defeated in House vote
March 14, 2018Research and Development, Sales and Marketing FDA, House of representatives, Right to try, US, pharma
The divisive and much-talked-about “right to try” legislation designed to provide access for terminally ill Americans to experimental and unproven …
World’s first synthetic, non-biologic vaccine developed
March 14, 2018Research and Development Vaccine, biotech, drugs, influenza, pharma, pharmaceutical
One of the major challenges in delivering vaccinations to all parts of the globe is the need to keep the …
AbbVie secures further strong results for potential blockbuster
March 13, 2018Research and Development AbbVie, biotech, drugs, elagolix, pharma, pharmaceutical
AbbVie’s elagolix has been slated as a blockbuster-in-the-making by analysts predicting big things for the potential treatment for uterine fibroids …
FDA inspection reveals cGMP issues at Biocon’s major Malaysia facility
March 13, 2018Manufacturing and Production Biocon, CGMP, FDA, pharma
Biocon’s insulin production facility in Johar, Malaysia – the largest integrated insulin manufacturing facility in Asia – has been slapped …
Adaxis-AZ immunotherapy combo hit by clinical hold after death
March 13, 2018Manufacturing and Production, Research and Development Adaxis, AstraZeneca, Imfinzi, biotech, drugs, immunotherapy, pharma, pharmaceutical
Adaxis and AstraZeneca announced that they had agreed a combination program for axalimogene filolisbac and Imfinzi, respectively, back in 2014 …
Anthera pulls the plug on Sollpura after Phase 3 failure, shares plummet 84%
March 13, 2018Manufacturing and Production, Research and Development Anthera, Eli Lilly, Sollpura, pharma, trial failure
Anthera Pharmaceuticals has announced that it is to terminate development of its investigational pancreatic enzyme replacement therapy (PERT) Sollpura after …
Novartis reshuffle begins under new CEO
March 13, 2018Manufacturing and Production, Medical Communications Novartis, biotech, digital, drugs, pharma, pharmaceutical
It’s a common strategy that newly appointed CEOs will try to change the direction of the company via rejigging leadership …
Pfizer begins sell-off, shedding CNS drug to Biogen for $590m
March 13, 2018Manufacturing and Production, Sales and Marketing Biogen, CNS, Pfizer, biotech, drugs, pharma, pharmaceutical
Pfizer’s decision to back out of the neuroscience space was a strategic move that send shudders through the entire industry, …
Drug safety: EudraVigilance and an evolving system
March 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug safety, pharma, pharmacovigilance
The importance of drug safety is back in the news due to sodium valproate and Ben Hargreaves examines how the …
AstraZeneca’s Brilinta proves safety in heart attack patients at Phase 3
March 12, 2018Research and Development, Sales and Marketing AstraZeneca, Brilinta, heart attack
AstraZeneca has revealed new Phase 3 data on its direct-acting P2Y12 receptor antagonist Brilinta (ticagrelor) at the American College of …
Impax agrees to $35 million settlement over anticompetitive practices with Valeant generic
March 12, 2018Sales and Marketing Impax, Medicis, Solodyn, Valeant, generic, pharma
Impax Pharmaceuticals has acquiesced to paying a $35 million settlement in order to resolve part of an antitrust lawsuit it …
Martin Shkreli sentenced to seven years in jail for securities fraud
March 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Martin Shkreli, pharma
Three years after he became “the most hated man in America” overnight for jacking up the price of life-saving HIV-related …
Sanofi and Regeneron reveal strong data and a price drop for Praluent
March 12, 2018Research and Development, Sales and Marketing Regeneron, Sanofi, pharma, praluent
Sanofi and Regeneron have revealed strong new data for its PCSK9 inhibitor Praluent showing the first-ever reduction in deaths within …
Hikma’s Advair generic delayed in the US
March 12, 2018Sales and Marketing Advair, FDA, GSK, GlaxoSmithKline, pharma
Hikma Pharmaceuticals has been knocked back with the news that the FDA has delayed approval of its generic lung treatment …
Top Ten most popular articles on Pharmafile.com this week
March 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Biogen, Celgene, EMA, Gilead, HIV, Herceptin, Japan, NHS, Ontruzant, Sanofi, opioid crisis, opioids, pharma, real world data, top ten, zinbryta
After a particularly jarring bout of cold weather and snow, we may just have seen off the worst of winter …
Latest content
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?
